Literature DB >> 33552987

LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes.

Duilia Brex1, Cristina Barbagallo1, Federica Mirabella1, Angela Caponnetto1, Rosalia Battaglia1, Davide Barbagallo1, Rosario Caltabiano2, Giuseppe Broggi2, Lorenzo Memeo3, Cinzia Di Pietro1, Michele Purrello1, Marco Ragusa1.   

Abstract

Long non-coding RNAs (lncRNAs) are the most heterogeneous class of non-protein-coding RNAs involved in a broad spectrum of molecular mechanisms controlling genome function, including the generation of complex networks of RNA-RNA competitive interactions. Accordingly, their dysregulation contributes to the onset of many tumors, including colorectal cancer (CRC). Through a combination of in silico approaches (statistical screening of expression datasets) and in vitro analyses (enforced expression, artificial inhibition, or activation of pathways), we identified LINC00483 as a potential tumor suppressor lncRNA in CRC. LINC00483 was downregulated in CRC biopsies and metastases and its decreased levels were associated with severe clinical features. Inhibition of the MAPK pathway and cell cycle arrest by starvation induced an upregulation of LINC00483, while the epithelial to mesenchymal transition activation by TGFβ-1 and IL-6 caused its down-modulation. Moreover, enforced expression of LINC00483 provoked a slowing down of cell migration rate without affecting cell proliferation. Since LINC00483 was predominantly cytoplasmic, we hypothesized a "miRNA sponge" role for it. Accordingly, we computationally reconstructed the LINC00483/miRNA/mRNA axes and evaluated the expression of mRNAs in different experimental conditions inducing LINC00483 alteration. By this approach, we identified a set of mRNAs sharing the miRNA response elements with LINC00483 and modulated in accordance with it. Moreover, we found that LINC00483 is potentially under negative control of transcription factor HNF4α. In conclusion, we propose that LINC00483 is a tumor suppressor in CRC that, through an RNA-RNA network, may control cell migration and participate in proliferation signaling.
Copyright © 2021 Brex, Barbagallo, Mirabella, Caponnetto, Battaglia, Barbagallo, Caltabiano, Broggi, Memeo, Di Pietro, Purrello and Ragusa.

Entities:  

Keywords:  HNF4α; IL-6; TGFβ-1; colorectal cancer; competing endogenous RNA; epithelial–mesenchymal transition; long non-coding RNAs; microRNAs

Year:  2021        PMID: 33552987      PMCID: PMC7855711          DOI: 10.3389/fonc.2020.614455

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  75 in total

1.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Alessandra Majorana; Davide Barbagallo; Loredana Salito; Mariangela Sammito; Manuela Santonocito; Rosario Angelica; Andrea Cavallaro; Marina Scalia; Rosario Caltabiano; Giuseppe Privitera; Antonio Biondi; Maria Di Vita; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Elisabetta Tendi; Salvatore Celeste; Cinzia Di Pietro; Francesco Basile; Michele Purrello
Journal:  J Mol Med (Berl)       Date:  2012-06-04       Impact factor: 4.599

2.  Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.

Authors:  Mounia Beloueche-Babari; L Elizabeth Jackson; Nada M S Al-Saffar; Paul Workman; Martin O Leach; Sabrina M Ronen
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  TGF-β signaling and epithelial-mesenchymal transition in cancer progression.

Authors:  Yoko Katsuno; Samy Lamouille; Rik Derynck
Journal:  Curr Opin Oncol       Date:  2013-01       Impact factor: 3.645

5.  Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.

Authors:  Aviram Nissan; Alexander Stojadinovic; Stella Mitrani-Rosenbaum; David Halle; Ronit Grinbaum; Marina Roistacher; Andrea Bochem; Baris Emre Dayanc; Gerd Ritter; Ismail Gomceli; Erdal Birol Bostanci; Musa Akoglu; Yao-Tseng Chen; Lloyd John Old; Ali Osmay Gure
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

6.  Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription.

Authors:  J Eeckhoute; P Formstecher; B Laine
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

7.  UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution.

Authors:  Yu Han; Ying-nan Yang; Heng-heng Yuan; Ting-ting Zhang; Hong Sui; Xiao-li Wei; Lei Liu; Peng Huang; Wen-jie Zhang; Yu-xian Bai
Journal:  Pathology       Date:  2014-08       Impact factor: 5.306

8.  Effects of interactions of hepatocyte nuclear factor 4alpha isoforms with coactivators and corepressors are promoter-specific.

Authors:  Maria Elena Torres-Padilla; Mary C Weiss
Journal:  FEBS Lett       Date:  2003-03-27       Impact factor: 4.124

9.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.

Authors:  Jeffrey C Barrett; James C Lee; Charles W Lees; Natalie J Prescott; Carl A Anderson; Anne Phillips; Emma Wesley; Kirstie Parnell; Hu Zhang; Hazel Drummond; Elaine R Nimmo; Dunecan Massey; Kasia Blaszczyk; Timothy Elliott; Lynn Cotterill; Helen Dallal; Alan J Lobo; Craig Mowat; Jeremy D Sanderson; Derek P Jewell; William G Newman; Cathryn Edwards; Tariq Ahmad; John C Mansfield; Jack Satsangi; Miles Parkes; Christopher G Mathew; Peter Donnelly; Leena Peltonen; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Mark I McCarthy; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Nilesh Samani; Richard C Trembath; Anath C Viswanathan; Nicholas Wood; Chris C A Spencer; Jeffrey C Barrett; Céline Bellenguez; Daniel Davison; Colin Freeman; Amy Strange; Peter Donnelly; Cordelia Langford; Sarah E Hunt; Sarah Edkins; Rhian Gwilliam; Hannah Blackburn; Suzannah J Bumpstead; Serge Dronov; Matthew Gillman; Emma Gray; Naomi Hammond; Alagurevathi Jayakumar; Owen T McCann; Jennifer Liddle; Marc L Perez; Simon C Potter; Radhi Ravindrarajah; Michelle Ricketts; Matthew Waller; Paul Weston; Sara Widaa; Pamela Whittaker; Panos Deloukas; Leena Peltonen; Christopher G Mathew; Jenefer M Blackwell; Matthew A Brown; Aiden Corvin; Mark I McCarthy; Chris C A Spencer; Antony P Attwood; Jonathan Stephens; Jennifer Sambrook; Willem H Ouwehand; Wendy L McArdle; Susan M Ring; David P Strachan
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

10.  MAPK signaling control of colon cancer metastasis.

Authors:  Jelena Urosevic; Angel R Nebreda; Roger R Gomis
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more
  6 in total

1.  PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer.

Authors:  Giorgio Ivan Russo; Nicolò Musso; Arturo Lo Giudice; Maria Giovanna Asmundo; Marina Di Mauro; Paolo G Bonacci; Mariacristina Massimino; Dalida Bivona; Stefania Stefani; Elisabetta Pricoco; Matteo Ferro; Massimo Camarda; Sebastiano Cimino; Giuseppe Morgia; Rosario Caltabiano; Giuseppe Broggi
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-16       Impact factor: 4.322

Review 2.  New Sights Into Long Non-Coding RNA LINC01133 in Cancer.

Authors:  Shengnan Jiang; Qian Zhang; Jiaqi Li; Khadija Raziq; Xinyu Kang; Shiyin Liang; Chaoyue Sun; Xiao Liang; Di Zhao; Songbin Fu; Mengdi Cai
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

3.  ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis.

Authors:  Jian Pu; Ya Zhang; Anmin Wang; Zebang Qin; Chenyi Zhuo; Wenchuan Li; Zuoming Xu; Qianli Tang; Jianchu Wang; Huamei Wei
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

4.  lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K/Akt/NF-κB Signal Pathway.

Authors:  Haibo Jia; Xiaoxiao Yan
Journal:  Biomed Res Int       Date:  2022-07-11       Impact factor: 3.246

5.  Quantitative Expression of SFN, lncRNA CCDC18-AS1, and lncRNA LINC01343 in Human Breast Cancer as the Regulator Biomarkers in a Novel ceRNA Network: Based on Bioinformatics and Experimental Analyses.

Authors:  Mehrnoush Rishehri; Tahereh Etemadi; Leila Pisheh; Ghazaleh Koufigar; Mansoureh Azadeh
Journal:  Genet Res (Camb)       Date:  2022-09-12       Impact factor: 1.375

6.  VECTOR: An Integrated Correlation Network Database for the Identification of CeRNA Axes in Uveal Melanoma.

Authors:  Cristina Barbagallo; Antonio Di Maria; Adriana Alecci; Davide Barbagallo; Salvatore Alaimo; Lorenzo Colarossi; Alfredo Ferro; Cinzia Di Pietro; Michele Purrello; Alfredo Pulvirenti; Marco Ragusa
Journal:  Genes (Basel)       Date:  2021-06-29       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.